Setting

Europe Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity

Published: 30 Jun 2022 | Report Code: 10248544 | Pages: 122

Europe nutrigenomics market was valued at $187.2 million in 2021 and will grow by 14.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 35 tables and 59 figures, this 122-page report “Europe Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Country. Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Products o Probiotics o Prebiotics o Vitamins & Supplements • Testing Services o Nutrigenomics Clinical Testing o Nutrigenomics Research Testing Based on Test Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Next-generation Sequencing • Real-time PCR • DNA Microarray • Sanger Sequencing By Test Sample, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Buccal Swab Sample • Saliva Sample • Blood Sample • Other Samples By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Women’s Health • Metabolic Disorders • Immune Health • Cancer Research • Cardiovascular Diseases • Diabetes • Other Applications By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Nutrition Clinics • Diagnostics Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering?Application and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BASF SE BioGaia Cell Logic Cura Integrative Medicine DNAfit DuPont de Nemours, Inc. Garden of Life, LLC GeneOmbio Genova Diagnostics, Inc. GX Sciences, Inc. Ingredion Incorporated Jarrow Formulas Inc. Koninklijke DSM N.V. MedGenome Metagenics, Inc. Nutrigenomix Inc. Unilever Group XCODE Life Yakult Honsha Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:
1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	24
2.2 Major Growth Drivers	26
2.3 Market Restraints and Challenges	34
2.4 Emerging Opportunities and Market Trends	37
2.5 Porter’s Fiver Forces Analysis	41
3 Segmentation of Europe Market by Offering	45
3.1 Market Overview by Offering	45
3.2 Products	47
3.3.1 Probiotics	48
3.3.2 Prebiotics	49
3.3.3 Vitamins & Supplements	50
3.3 Testing Services	51
3.3.1 Nutrigenomics Clinical Testing	52
3.3.2 Nutrigenomics Research Testing	53
4 Segmentation of Europe Market by Test Technology	54
4.1 Market Overview by Test Technology	54
4.2 Next-generation Sequencing	56
4.3 Real-time PCR	57
4.4 DNA Microarray	58
4.5 Sanger Sequencing	59
5 Segmentation of Europe Market by Test Sample	60
5.1 Market Overview by Test Sample	60
5.2 Buccal Swab Sample	62
5.3 Saliva Sample	63
5.4 Blood Sample	64
5.5 Other Samples	65
6 Segmentation of Europe Market by Application	66
6.1 Market Overview by Application	66
6.2 Women’s Health	68
6.3 Metabolic Disorders	69
6.4 Immune Health	70
6.5 Cancer Research	71
6.6 Cardiovascular Diseases	72
6.7 Diabetes	73
6.8 Other Applications	74
7 Segmentation of Europe Market by End User	75
7.1 Market Overview by End User	75
7.2 Hospitals	77
7.3 Nutrition Clinics	78
7.4 Diagnostics Laboratories	79
7.5 Other End Users	80
8 European Market 2021-2031 by Country	81
8.1 Overview of European Market	81
8.2 Germany	84
8.3 U.K.	86
8.4 France	88
8.5 Spain	90
8.6 Italy	92
8.7 Netherlands	94
8.8 Rest of European Market	96
9 Competitive Landscape	98
9.1 Overview of Key Vendors	98
9.2 New Product Launch, Partnership, Investment, and M&A	101
9.3 Company Profiles	102
BASF SE	102
BioGaia	104
Cell Logic	105
Cura Integrative Medicine	106
DNAfit	107
DuPont de Nemours, Inc.	108
Garden of Life, LLC	109
GeneOmbio	110
Genova Diagnostics, Inc.	111
GX Sciences, Inc.	112
Ingredion Incorporated	113
Jarrow Formulas Inc.	114
Koninklijke DSM N.V.	115
MedGenome	116
Metagenics, Inc.	117
Nutrigenomix Inc.	118
Unilever Group	119
XCODE Life	120
Yakult Honsha Co., Ltd.	121
RELATED REPORTS	122
List of Tables:

Table 1.  Snapshot of Europe Nutrigenomics Market in Balanced Perspective, 2021-2031	17
Table 2. World Economic Outlook, 2021-2031	21
Table 3. World Economic Outlook, 2021-2023	22
Table 4. World Health Spending by Region, $ bn, 2013-2020	33
Table 5.  Main Product Trends and Market Opportunities in Europe Nutrigenomics Market	37
Table 6. Europe Nutrigenomics Market by Offering, 2021-2031, $ mn	45
Table 7. Europe Nutrigenomics Market: Products by Type, 2021-2031, $ mn	47
Table 8. Europe Nutrigenomics Market: Testing Services by Type, 2021-2031, $ mn	51
Table 9. Europe Nutrigenomics Market by Test Technology, 2021-2031, $ mn	54
Table 10. Europe Nutrigenomics Market by Test Sample, 2021-2031, $ mn	60
Table 11. Europe Nutrigenomics Market by Application, 2021-2031, $ mn	66
Table 12. Europe Nutrigenomics Market by End User, 2021-2031, $ mn	75
Table 13. Europe Nutrigenomics Market by Country, 2021-2031, $ mn	83
Table 14. Germany Nutrigenomics Market by Offering, 2021-2031, $ mn	85
Table 15. Germany Nutrigenomics Market by Application, 2021-2031, $ mn	85
Table 16. Germany Nutrigenomics Market by End User, 2021-2031, $ mn	85
Table 17. U.K. Nutrigenomics Market by Offering, 2021-2031, $ mn	87
Table 18. U.K. Nutrigenomics Market by Application, 2021-2031, $ mn	87
Table 19. U.K. Nutrigenomics Market by End User, 2021-2031, $ mn	87
Table 20. France Nutrigenomics Market by Offering, 2021-2031, $ mn	89
Table 21. France Nutrigenomics Market by Application, 2021-2031, $ mn	89
Table 22. France Nutrigenomics Market by End User, 2021-2031, $ mn	89
Table 23. Spain Nutrigenomics Market by Offering, 2021-2031, $ mn	91
Table 24. Spain Nutrigenomics Market by Application, 2021-2031, $ mn	91
Table 25. Spain Nutrigenomics Market by End User, 2021-2031, $ mn	91
Table 26. Italy Nutrigenomics Market by Offering, 2021-2031, $ mn	93
Table 27. Italy Nutrigenomics Market by Application, 2021-2031, $ mn	93
Table 28. Italy Nutrigenomics Market by End User, 2021-2031, $ mn	93
Table 29. Netherlands Nutrigenomics Market by Offering, 2021-2031, $ mn	95
Table 30. Netherlands Nutrigenomics Market by Application, 2021-2031, $ mn	95
Table 31. Netherlands Nutrigenomics Market by End User, 2021-2031, $ mn	95
Table 32. Nutrigenomics Market in Rest of Europe by Country, 2021-2031, $ mn	97
Table 33. BASF SE: Company Snapshot	102
Table 34. BASF SE: Business Segmentation	103
Table 35. BASF SE: Product Portfolio	103
List of Figures:

Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	16
Figure 4. Europe Nutrigenomics Market, 2021-2031, $ mn	19
Figure 5. Impact of COVID-19 on Business	24
Figure 6. Primary Drivers and Impact Factors of Europe Nutrigenomics Market	26
Figure 7. Number of Overweight/Obese People and Diabetic Population in the World, 1980, 2020, and 2045F, in million	29
Figure 8.  Leading Causes of Death in the World, 2019-2020, million	31
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	32
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	32
Figure 11. Primary Restraints and Impact Factors of Europe Nutrigenomics Market	34
Figure 12. Investment Opportunity Analysis	38
Figure 13. Porter’s Fiver Forces Analysis of Europe Nutrigenomics Market	41
Figure 14. Breakdown of Europe Nutrigenomics Market by Offering, 2021-2031, % of Revenue	46
Figure 15. Europe Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	46
Figure 16. Europe Nutrigenomics Market by Offering: Products, 2021-2031, $ mn	47
Figure 17. Europe Nutrigenomics Market by Products: Probiotics, 2021-2031, $ mn	48
Figure 18. Europe Nutrigenomics Market by Products: Prebiotics, 2021-2031, $ mn	49
Figure 19. Europe Nutrigenomics Market by Products: Vitamins & Supplements, 2021-2031, $ mn	50
Figure 20. Europe Nutrigenomics Market by Offering: Testing Services, 2021-2031, $ mn	51
Figure 21. Europe Nutrigenomics Market by Testing Services: Nutrigenomics Clinical Testing, 2021-2031, $ mn	52
Figure 22. Europe Nutrigenomics Market by Testing Services: Nutrigenomics Research Testing, 2021-2031, $ mn	53
Figure 23. Breakdown of Europe Nutrigenomics Market by Test Technology, 2021-2031, % of Sales Revenue	55
Figure 24. Europe Addressable Market Cap in 2022-2031 by Test Technology, Value ($ mn) and Share (%)	55
Figure 25. Europe Nutrigenomics Market by Test Technology: Next-generation Sequencing, 2021-2031, $ mn	56
Figure 26. Europe Nutrigenomics Market by Test Technology: Real-time PCR, 2021-2031, $ mn	57
Figure 27. Europe Nutrigenomics Market by Test Technology: DNA Microarray, 2021-2031, $ mn	58
Figure 28. Europe Nutrigenomics Market by Test Technology: Sanger Sequencing, 2021-2031, $ mn	59
Figure 29. Breakdown of Europe Nutrigenomics Market by Test Sample, 2021-2031, % of Sales Revenue	61
Figure 30. Europe Addressable Market Cap in 2022-2031 by Test Sample, Value ($ mn) and Share (%)	61
Figure 31. Europe Nutrigenomics Market by Test Sample: Buccal Swab Sample, 2021-2031, $ mn	62
Figure 32. Europe Nutrigenomics Market by Test Sample: Saliva Sample, 2021-2031, $ mn	63
Figure 33. Europe Nutrigenomics Market by Test Sample: Blood Sample, 2021-2031, $ mn	64
Figure 34. Europe Nutrigenomics Market by Test Sample: Other Samples, 2021-2031, $ mn	65
Figure 35. Breakdown of Europe Nutrigenomics Market by Application, 2021-2031, % of Revenue	67
Figure 36. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	67
Figure 37. Europe Nutrigenomics Market by Application: Women’s Health, 2021-2031, $ mn	68
Figure 38. Europe Nutrigenomics Market by Application: Metabolic Disorders, 2021-2031, $ mn	69
Figure 39. Europe Nutrigenomics Market by Application: Immune Health, 2021-2031, $ mn	70
Figure 40. Europe Nutrigenomics Market by Application: Cancer Research, 2021-2031, $ mn	71
Figure 41. Europe Nutrigenomics Market by Application: Cardiovascular Diseases, 2021-2031, $ mn	72
Figure 42. Europe Nutrigenomics Market by Application: Diabetes, 2021-2031, $ mn	73
Figure 43. Europe Nutrigenomics Market by Application: Other Applications, 2021-2031, $ mn	74
Figure 44. Breakdown of Europe Nutrigenomics Market by End User, 2021-2031, % of Revenue	76
Figure 45. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	76
Figure 46. Europe Nutrigenomics Market by End User: Hospitals, 2021-2031, $ mn	77
Figure 47. Europe Nutrigenomics Market by End User: Nutrition Clinics, 2021-2031, $ mn	78
Figure 48. Europe Nutrigenomics Market by End User: Diagnostics Laboratories, 2021-2031, $ mn	79
Figure 49. Europe Nutrigenomics Market by End User: Other End Users, 2021-2031, $ mn	80
Figure 50. Breakdown of European Nutrigenomics Market by Country, 2021 and 2031, % of Revenue	82
Figure 51. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	83
Figure 52.  Nutrigenomics Market in Germany, 2021-2031, $ mn	84
Figure 53.  Nutrigenomics Market in U.K., 2021-2031, $ mn	86
Figure 54.  Nutrigenomics Market in France, 2021-2031, $ mn	88
Figure 55.  Nutrigenomics Market in Spain, 2021-2031, $ mn	90
Figure 56.  Nutrigenomics Market in Italy, 2021-2031, $ mn	92
Figure 57.  Nutrigenomics Market in Netherlands, 2021-2031, $ mn	94
Figure 58.  Nutrigenomics Market in Rest of Europe, 2021-2031, $ mn	96
Figure 59. Growth Stage of Europe Nutrigenomics Industry over the Forecast Period	98
Selected Key Players: 
BASF SE
BioGaia
Cell Logic
Cura Integrative Medicine
DNAfit
DuPont de Nemours, Inc.
Garden of Life, LLC
GeneOmbio
Genova Diagnostics, Inc.
GX Sciences, Inc.
Ingredion Incorporated
Jarrow Formulas Inc.
Koninklijke DSM N.V.
MedGenome
Metagenics, Inc.
Nutrigenomix Inc.
Unilever Group
XCODE Life
Yakult Honsha Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)